O
Ole Jakob Storebø
Researcher at University of Southern Denmark
Publications - 81
Citations - 1823
Ole Jakob Storebø is an academic researcher from University of Southern Denmark. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Medicine. The author has an hindex of 17, co-authored 69 publications receiving 1312 citations. Previous affiliations of Ole Jakob Storebø include Region Zealand & Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Ole Jakob Storebø,Erica Ramstad,Helle B Krogh,Trine Danvad Nilausen,Maria Skoog,Mathilde Holmskov,Susanne Rosendal,Camilla Groth,Frederik L Magnusson,Carlos Renato Moreira-Maia,Donna Gillies,Kirsten Buch Rasmussen,Dorothy Gauci,Morris Zwi,Richard Kirubakaran,Bente Forsbøl,Erik Simonsen,Erik Simonsen,Christian Gluud +18 more
TL;DR: Methylphenidate may improve teacher-rated ADHD symptoms and downgraded evidence according to the Grades of Recommendation, Assessment, Development and Evaluation approach for high risk of bias, imprecision, indirectness, heterogeneity and publication bias is assessed.
Journal ArticleDOI
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
Ole Jakob Storebø,Nadia Pedersen,Erica Ramstad,M.L. Kielsholm,SS Nielsen,Helle B Krogh,Carlos Renato Moreira-Maia,Frederik L Magnusson,Mathilde Holmskov,Trine Gerner,Maria Skoog,Susanne Rosendal,Camilla Groth,Donna Gillies,Kirsten Buch Rasmussen,Dorothy Gauci,Morris Zwi,Richard Kirubakaran,Sasja Jul Håkonsen,Lise Aagaard,Erik Simonsen,Christian Gluud +21 more
TL;DR: A systematic review of randomised clinical trials (RCTs) for methylphenidate treatment for children and adolescents with ADHD demonstrated no increase in serious adverse events, but a high proportion of participants suffered a range of non-serious adverse events.
Journal ArticleDOI
Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials
Ole Jakob Storebø,Ole Jakob Storebø,Helle B Krogh,Erica Ramstad,Carlos Renato Moreira-Maia,Mathilde Holmskov,Maria Skoog,Trine Danvad Nilausen,Frederik L Magnusson,Morris Zwi,Donna Gillies,Susanne Rosendal,Camilla Groth,Kirsten Buch Rasmussen,Dorothy Gauci,Richard Kirubakaran,Bente Forsbøl,Erik B. Simonsen,Erik B. Simonsen,Christian Gluud +19 more
TL;DR: The results suggest that among children and adolescents with a diagnosis of ADHD, methylphenidate may improve teacher reported symptoms of ADHD and general behaviour and parent reported quality of life.
Journal ArticleDOI
Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
TL;DR: There is little evidence to support or refute social skills training for adolescents with ADHD, and the results are downgraded to low quality evidence.
Journal ArticleDOI
The Association Between ADHD and Antisocial Personality Disorder (ASPD): A Review
Ole Jakob Storebø,Erik Simonsen +1 more
TL;DR: There is an increased risk for children with ADHD with or without comorbid CD to develop later onset of antisocial personality disorder.